BADAK, B. Et Al. 2021. Nilco signaling is a novel biomarker in thyroid cancer. Acta Medica Mediterranea , vol.37, no.5 , 2625-2629.

BADAK, B., Özyurt, R., ERKASAP, N., ÖZKURT, M., Güzel, D., Erkasap, S., ... Ihtiya, E.(2021). Nilco signaling is a novel biomarker in thyroid cancer. Acta Medica Mediterranea , vol.37, no.5, 2625-2629.

BADAK, BARTU Et Al. "Nilco signaling is a novel biomarker in thyroid cancer," Acta Medica Mediterranea , vol.37, no.5, 2625-2629, 2021

BADAK, BARTU Et Al. "Nilco signaling is a novel biomarker in thyroid cancer." Acta Medica Mediterranea , vol.37, no.5, pp.2625-2629, 2021

BADAK, B. Et Al. (2021) . "Nilco signaling is a novel biomarker in thyroid cancer." Acta Medica Mediterranea , vol.37, no.5, pp.2625-2629.

@article{article, author={BARTU BADAK Et Al. }, title={Nilco signaling is a novel biomarker in thyroid cancer}, journal={Acta Medica Mediterranea}, year=2021, pages={2625-2629} }